Emerging biopharmaceuticals from bioactive peptides derived from marine organisms.

Abstract

Biologically active natural products are spontaneous medicinal entrants, which encourage synthetic access for enhancing and supporting drug discovery and development. Marine bioactive peptides are considered as a rich source of natural products that may provide long-term health, in addition to many prophylactic and curative medicinal drug treatments. The large literature concerning marine peptides has been collected, which shows high potential of nutraceutical and therapeutic efficacy encompassing wide spectra of bioactivities against a number of infection-causing agents. Their antimicrobial, antimalarial, antitumor, antiviral, and cardioprotective actions have achieved the attention of the pharmaceutical industry toward new design of drug formulations, for treatment and prevention of several infections. However, the mechanism of action of many peptide molecules has been still untapped. So in this regard, this paper reviews several peptide compounds by which they interfere with human pathogenesis. This knowledge is one of the key tools to be understood especially for the biotransformation of biomolecules into targeted medicines. The fact that different diseases have the capability to fight at different sites inside the body can lead to a new wave of increasing the chances to produce targeted medicines.

DOI: 10.1111/cbdd.12925

14 Figures and Tables

Cite this paper

@article{Anjum2017EmergingBF, title={Emerging biopharmaceuticals from bioactive peptides derived from marine organisms.}, author={Komal Anjum and Syed Qamar Abbas and Najeeb Akhter and Bibi Ibtesam Shagufta and Sayed Asmat Ali Shah and Syed Shams Ul Hassan}, journal={Chemical biology & drug design}, year={2017}, volume={90 1}, pages={12-30} }